Cucurbitacin derivatives (B, IIa, IIb, and E): modulating gut dysbiosis and inflammatory pathways for multi-target therapy of ulcerative colitis

Inflammopharmacology · Published 2026-06-15 · DOI 10.1007/s10787-026-02284-5

Authors (5)

Radha Devi, Pyush Dadwal, Nitin Sharma, Amandeep Singh, Akshita Arora

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Devi, R., Dadwal, P., Sharma, N., et al. (2026). Cucurbitacin derivatives (B, IIa, IIb, and E): modulating gut dysbiosis and inflammatory pathways for multi-target therapy of ulcerative colitis. Inflammopharmacology. https://doi.org/10.1007/s10787-026-02284-5

Related articles

• REJENERA©, a multi-component bioflavonoid-based formula, alleviates osteoarthritis and provides chondroprotection by regulating the NLRP3-TXNIP-iNOS axis and inflammation: a comparative study with olive leaf nutraceuticals and ibuprofen · Inflammopharmacology · 2026 · Same journal
• Antioxidative and anti-inflammatory effects of monoterpene linalool in rats with letrozole-induced polycystic ovarian syndrome: modulation of autophagy and apoptosis · Inflammopharmacology · 2026 · Same journal
• Mangiferin in combination with primaquine reduces disease progression and transmission potential while alleviating cerebral pathology through suppression of neural cell apoptosis in experimental cerebral malaria · Inflammopharmacology · 2026 · Same journal
• Regulation of NLRP3 inflammasome signaling in Alzheimer’s disease: emerging neuroprotective role of phytochemicals · Inflammopharmacology · 2026 · Same journal
• Agomelatine for Sjögren’s syndrome: a study on its therapeutic effects and mechanisms · Inflammopharmacology · 2026 · Same journal
• The lung–brain axis in neurodegeneration: inflammatory, immune, and vascular mechanisms with therapeutic implications · Inflammopharmacology · 2026 · Same journal
• Therapeutic and research frontiers in fibromyalgia: integrating pathophysiology with innovative drug repurposing · Inflammopharmacology · 2026 · Same journal
• Cytotoxic and computational profiling of 2-mercaptobenzimidazole Mannich derivatives: structure activity relationship and carbonic anhydrase binding assessment · Inflammopharmacology · 2026 · Same journal
• Anti-inflammatory evaluation of HPLC-GC quantified phytochemicals from Acalypha indica L. using LPS-induced inflammation model · Inflammopharmacology · 2026 · Same journal
• Cortistatin as a pleiotropic regulator of neuroimmune and inflammatory pathways in experimental disease: a scoping review of preclinical evidence · Inflammopharmacology · 2026 · Same journal